Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response
Open accessAbstract
The Keap1-Nrf2 system plays a central role in cytoprotection against electrophilic/oxidative stresses. Although Cys151, Cys273, and Cys288 of Keap1 are major sensor cysteine residues for detecting these stresses, it has not been technically feasible to evaluate the functionality of Cys273 or Cys288, since Keap1 mutants that harbor substitutions in these residues and maintain the ability to repress Nrf2 accumulation do not exist. To overcome this problem, we systematically introduced amino acid substitutions into Cys273/Cys288 and finally identified Cys273Trp and Cys288Glu mutations that do not affect Keap1's ability to repress Nrf2 accumulation. Utilizing these Keap1 mutants, we generated stable murine embryonic fibroblast (MEF) cell lines and knock-in mouse lines. Our analyses with the MEFs and peritoneal macrophages from the knock-in mice revealed that three major cysteine residues, Cys151, Cys273, and Cys288, individually and/or redundantly act as sensors. Based on the functional necessity of these three cysteine residues, we categorized chemical inducers of Nrf2 into four classes. Class I and II utilizes Cys151 and Cys288, respectively, while class III requires all three residues (Cys151/Cys273/Cys288), while class IV inducers function independently of all three of these cysteine residues. This study thus demonstrates that Keap1 utilizes multiple cysteine residues specifically and/or collaboratively as sensors for the detection of a wide range of environmental stresses.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tumour-infiltrating macrophages release itaconate which potentiates tumour growth in peritoneal tumours (B16 melanoma and ID8 ovarian carcinoma).
“Most recently, an intriguing study in peritoneal tumours (B16 melanoma and ID8 ovarian carcinoma) has demonstrated that tumour-infiltrating macrophages release itaconate which potentiates tumour growth74.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [74]
Itaconate boosts OXPHOS and mtROS generation and subsequent MAPK activation in tumour-infiltrating macrophages.
“Itaconate was shown to boost OXPHOS and mtROS generation and subsequent MAPK activation in tumour-infiltrating macrophages (Figure 3).”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999 · see citing works
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · see citing works
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495 · see citing works
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224 · see citing works
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947 · see citing works
Self-citationZhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · see citing works
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,262 · see citing works
Molecular basis of the Keap1–Nrf2 system
Suzuki, T., & Yamamoto, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.006 · Cited by 995 · see citing works
Self-citationWakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986 · see citing works
Self-citationKeap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation
Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., KOTSUJI, T., Otsuka, F., Roop, D. R., et al. (2003) · Nature Genetics · doi:10.1038/ng1248 · Cited by 881 · see citing works
Self-citationShibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728 · see citing works
Self-citationToward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680 · see citing works
Self-citationKobayashi, M., Li, L., Iwamoto, N., Nakajima‐Takagi, Y., Kaneko, H., Nakayama, Y., Eguchi, M., Wada, Y., Kumagai, Y., & Yamamoto, M. P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01080-08 · Cited by 641 · see citing works
Self-citationLoss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
Ohta, T., Iijima, K., Miyamoto, M., Nakahara, I., Tanaka, H., Ohtsuji, M., Suzuki, T., Kobayashi, A., Yokota, J., Sakiyama, T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5003 · Cited by 630 · see citing works
Self-citationKang, M.-I., Kobayashi, A., Wakabayashi, N., Kim, S.-G., & Yamamoto, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308347100 · Cited by 536 · see citing works
Self-citationDirect and indirect antioxidant properties of inducers of cytoprotective proteins
Dinkova‐Kostova, A. T., & Talalay, P. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700195 · Cited by 535 · see citing works
Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity
Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J. M., Motohashi, H., & Yamamoto, M. P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01704-07 · Cited by 515 · see citing works
Self-citationEggler, A. L., Liu, G., Pezzuto, J. M., van Breemen, R. B., & Mesecar, A. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502402102 · Cited by 459 · see citing works
Tong, K. I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S., & Yamamoto, M. P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00753-07 · Cited by 447 · see citing works
Self-citationMcMahon, M. J., Lamont, D. J., Beattie, K. A., & Hayes, J. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007387107 · Cited by 445 · see citing works
Hong, F., Freeman, M. L., & Liebler, D. C. (2005) · Chemical Research in Toxicology · doi:10.1021/tx0502138 · Cited by 404 · see citing works
The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus
Uruno, A., Furusawa, Y., Yagishita, Y., Fukutomi, T., Muramatsu, H., Negishi, T., Sugawara, A., Kensler, T. W., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00225-13 · Cited by 330 · see citing works
Self-citationModification of Keap1 Cysteine Residues by Sulforaphane
Hu, C., Eggler, A. L., Mesecar, A. D., & van Breemen, R. B. (2011) · Chemical Research in Toxicology · doi:10.1021/tx100389r · Cited by 312 · see citing works
Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases
Canning, P., Cooper, C. D. O., Krojer, T., Murray, J. W., Pike, A. C. W., Chaikuad, A., Keates, T., Thangaratnarajah, C., Hojzan, V., Marsden, B. D., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437996 · Cited by 284 · see citing works
Gao, L., Wang, J., Sekhar, K. R., Yin, H., Yared, N. F., Schneider, S. N., Sasi, S., Dalton, T. P., Anderson, M. E., Chan, J. Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607622200 · Cited by 278 · see citing works
Validation of the multiple sensor mechanism of the Keap1-Nrf2 system
Takaya, K., Suzuki, T., Motohashi, H., Onodera, K., Satomi, S., Kensler, T. W., & Yamamoto, M. P. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.023 · Cited by 277 · see citing works
Self-citationFukutomi, T., Takagi, K., Mizushima, T., Ohuchi, N., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01191-13 · Cited by 265 · see citing works
Self-citationStructure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
Cleasby, A., Yon, J. R., Day, P. J., Richardson, C. J., Tickle, I. J., Williams, P. A., Callahan, J. F., Carr, R. A. E., Concha, N. O., Kerns, J. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098896 · Cited by 263 · see citing works
Update on the Kelch-like (KLHL) gene family
Dhanoa, B. S., Cogliati, T., Satish, A. G., Bruford, E. A., & Friedman, J. S. (2013) · Human Genomics · doi:10.1186/1479-7364-7-13 · Cited by 260 · see citing works
Hourihan, J. M., Kenna, J. G., & Hayes, J. D. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4944 · Cited by 232 · see citing works
Ogura, T., Tong, K. I., Mio, K., Maruyama, Y., Kurokawa, H., Sato, C., & Yamamoto, M. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914036107 · Cited by 232 · see citing works
Self-citationRachakonda, G., Xiong, Y., Sekhar, K. R., Stamer, S. L., Liebler, D. C., & Freeman, M. L. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700302s · Cited by 210 · see citing works
Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism
Kansanen, E., Bonacci, G., Schopfer, F. J., Kuosmanen, S. M., Tong, K. I., Leinonen, H., Woodcock, S. R., Yamamoto, M., Carlberg, C., Ylä-Herttuala, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190710 · Cited by 208 · see citing works
Self-citationMechanism of Chemical Activation of Nrf2
Li, Y., Paonessa, J. D., & Zhang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035122 · Cited by 179 · see citing works
Eggler, A. L., Small, E., Hannink, M., & Mesecar, A. D. (2009) · Biochemical Journal · doi:10.1042/bj20090471 · Cited by 178 · see citing works
Fujii, S., Sawa, T., Ihara, H., Tong, K. I., Ida, T., Okamoto, T., Ahmed, K. A., Ishima, Y., Motohashi, H., Yamamoto, M. P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145441 · Cited by 151 · see citing works
Self-citationSubcellular localization and cytoplasmic complex status of endogenous Keap1
Watai, Y., Kobayashi, A., Nagase, H., Mizukami, M., McEvoy, J. D., Singer, J. D., Itoh, K., & Yamamoto, M. P. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01118.x · Cited by 138 · see citing works
Self-citationRegulatory Nexus of Synthesis and Degradation Deciphers Cellular Nrf2 Expression Levels
Suzuki, T., Shibata, T., Takaya, K., Shiraishi, K., Kohno, T., Kunitoh, H., Tsuta, K., Furuta, K., Goto, K., Hosoda, F., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00065-13 · Cited by 123 · see citing works
Self-citationMaruyama, A., Tsukamoto, S., Nishikawa, K., Yoshida, A., Harada, N., Motojima, K., Ishii, T., Nakane, A., Yamamoto, M. P., & Itoh, K. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.06.004 · Cited by 99 · see citing works
Self-citationNrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers
Taguchi, K., Hirano, I., Itoh, T., Tanaka, M., Miyajima, A., Suzuki, A., Motohashi, H., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01384-13 · Cited by 98 · see citing works
Self-citationSuzuki, T., Kelly, V. P., Motohashi, H., Nakajima, O., Takahashi, S., Nishimura, S., & Yamamoto, M. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708352200 · Cited by 91 · see citing works
Self-citationEggler, A. L., Luo, Y., van Breemen, R. B., & Mesecar, A. D. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700217c · Cited by 80 · see citing works
Tsujita, T., Li, L., Nakajima, H., Iwamoto, N., Nakajima‐Takagi, Y., Ohashi, K., Kawakami, K., Kumagai, Y., Freeman, B. Α., Yamamoto, M. P., et al. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01466.x · Cited by 78 · see citing works
Self-citationDiffusion dynamics of the Keap1–Cullin3 interaction in single live cells
Baird, L., & Dinkova‐Kostova, A. T. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.065 · Cited by 59 · see citing works
Self-citationSelect Heterozygous Keap1 Mutations Have a Dominant-Negative Effect on Wild-Type Keap1 In Vivo
Suzuki, T., Maher, J. M., & Yamamoto, M. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2939 · Cited by 55 · see citing works
Self-citationNrf2 degron-fused reporter system: a new tool for specific evaluation of Nrf2 inducers
Hirotsu, Y., Katsuoka, F., Itoh, K., & Yamamoto, M. P. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01496.x · Cited by 20 · see citing works
Self-citationAbstract 1700: TLR4 as a novel determinant of paclitaxel response in metastatic breast cancer
Rajput, S., Boral, D., & Ran, S. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-1700 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968 · see citing works
Self-citationThe Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
Baird, L., & Yamamoto, M. P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00099-20 · Cited by 1,600 · see citing works
Self-citationTherapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,474 · see citing works
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · see citing works
The Dual Roles of NRF2 in Cancer
Menegon, S., Columbano, A., & Giordano, S. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.05.002 · Cited by 633 · see citing works
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632 · see citing works
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
Robledinos-Antón, N., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9372182 · Cited by 608 · see citing works
The KEAP1–NRF2 System in Cancer
Taguchi, K., & Yamamoto, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00085 · Cited by 527 · see citing works
Self-citationThe Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging
Yu, C., & Xiao, J.-H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6635460 · Cited by 537 · see citing works
Oxidative stress and diabetes: antioxidative strategies
Zhang, P., Li, T., Wu, X., Nice, E., Huang, C.-H., & Zhang, Y. (2020) · Frontiers in Medicine · doi:10.1007/s11684-019-0729-1 · Cited by 465 · see citing works
Reactive Oxygen Species in Macrophages: Sources and Targets
Canton, M., Sánchez‐Rodríguez, R., Spera, I., Venegas, F. C., Favia, M., Viola, A., & Castegna, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.734229 · Cited by 463 · see citing works
Suzuki, T., & Yamamoto, M. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.800169 · Cited by 402 · see citing works
Self-citationCoupling Krebs cycle metabolites to signalling in immunity and cancer
Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0014-7 · Cited by 398 · see citing works
RONS and Oxidative Stress: An Overview of Basic Concepts
Aranda‐Rivera, A. K., Cruz‐Gregorio, A., Arancibia‐Hernández, Y. L., Cruz, E. Y. H., & Pedraza‐Chaverrí, J. (2022) · Oxygen · doi:10.3390/oxygen2040030 · Cited by 406 · see citing works
Redox Signaling by Reactive Electrophiles and Oxidants
Parvez, S., Long, M. J. C., Poganik, J. R., & Aye, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00698 · Cited by 357 · see citing works
Environmental pollutants and the immune response
Suzuki, T., Hidaka, T., Kumagai, Y., & Yamamoto, M. P. (2020) · Nature Immunology · doi:10.1038/s41590-020-0802-6 · Cited by 356 · see citing works
Self-citationKeap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants
Dinkova‐Kostova, A. T., Kostov, R. V., & Canning, P. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.08.005 · Cited by 332 · see citing works
Molecular Basis of the KEAP1-NRF2 Signaling Pathway
Suzuki, T., Takahashi, J. A., & Yamamoto, M. P. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0028 · Cited by 309 · see citing works
Self-citationThe KEAP1-NRF2 pathway: Targets for therapy and role in cancer
Adinolfi, S., Patinen, T., Deen, A. J., Pitkänen, S., Härkönen, J., Kansanen, E., Küblbeck, J., & Levonen, A. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102726 · Cited by 301 · see citing works
Molecular Mechanism of Cellular Oxidative Stress Sensing by Keap1
Suzuki, T., Muramatsu, A., Saito, R., Iso, T., Shibata, T., Kuwata, K., Kawaguchi, S.-I., Iwawaki, T., Adachi, S., Suda, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.047 · Cited by 289 · see citing works
Self-citationBeyond repression of Nrf2: An update on Keap1
Kopacz, A., Klóska, D., Forman, H. J., Józkowicz, A., & Grochot‐Przeczek, A. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.03.023 · Cited by 262 · see citing works
Marchev, A. S., Dimitrova, P. A., Burns, A. J., Kostov, R. V., Dinkova‐Kostova, A. T., & Georgiev, M. I. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13407 · Cited by 223 · see citing works
Nrf2 and oxidative stress in liver ischemia/reperfusion injury
Bardallo, R. G., Rosello, A. P., Sánchez-Nuño, S., Alva, N., Roselló‐Catafau, J., & Carbonell, T. (2021) · FEBS Journal · doi:10.1111/febs.16336 · Cited by 208 · see citing works
Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism
Horie, Y., Suzuki, T., Inoue, J., Iso, T., Wells, G., Moore, T. W., Mizushima, T., Dinkova‐Kostova, A. T., Kasai, T., Kamei, T., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02100-6 · Cited by 195 · see citing works
Self-citationNRF2: KEAPing Tumors Protected
Pillai, R., Hayashi, M., Zavitsanou, A.-M., & Papagiannakopoulos, T. Y. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0922 · Cited by 187 · see citing works
Conservation of the Keap1-Nrf2 System: An Evolutionary Journey through Stressful Space and Time
Fuse, Y., & Kobayashi, M. (2017) · Molecules · doi:10.3390/molecules22030436 · Cited by 168 · see citing works
Nrf2 Suppresses Oxidative Stress and Inflammation in App Knock-In Alzheimer’s Disease Model Mice
Uruno, A., Matsumaru, D., Ryoke, R., Saito, R., Kadoguchi, S., Saigusa, D., Saito, T., Saido, T. C., Kawashima, R., & Yamamoto, M. P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00467-19 · Cited by 166 · see citing works
Self-citationKlotz, L., & Steinbrenner, H. (2017) · Redox Biology · doi:10.1016/j.redox.2017.07.015 · Cited by 165 · see citing works
Esteras, N., Dinkova‐Kostova, A. T., & Abramov, A. Y. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0295 · Cited by 161 · see citing works
Bardoxolone conjugation enables targeted protein degradation of BRD4
Tong, B., Luo, M., Xie, Y., Spradlin, J. N., Tallarico, J. A., McKenna, J. M., Schirle, M., Maimone, T. J., & Nomura, D. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-72491-9 · Cited by 149 · see citing works
KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy
Shekh‐Ahmad, T., Eckel, R., Naidu, S. D., Higgins, M., Yamamoto, M. P., Dinkova‐Kostova, A. T., Kovac, S., Abramov, A. Y., & Walker, M. C. (2018) · Brain · doi:10.1093/brain/awy071 · Cited by 148 · see citing works
Self-citationTranscription factor NRF2 as a promising therapeutic target for Alzheimer’s disease
Qu, Z., Sun, J., Zhang, W., Yu, J., & Zhuang, C. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.028 · Cited by 140 · see citing works
Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells
Iso, T., Suzuki, T., Baird, L., & Yamamoto, M. P. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00389-16 · Cited by 130 · see citing works
Self-citationNrf2 Improves Leptin and Insulin Resistance Provoked by Hypothalamic Oxidative Stress
Yagishita, Y., Uruno, A., Fukutomi, T., Saito, R., Saigusa, D., Pi, J., Fukamizu, A., Sugiyama, F., Takahashi, S., & Yamamoto, M. P. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.064 · Cited by 129 · see citing works
Self-citationKEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease
Naidu, S. D., & Dinkova‐Kostova, A. T. (2020) · Open Biology · doi:10.1098/rsob.200105 · Cited by 129 · see citing works
Nrf2-Mediated Regulation of Skeletal Muscle Glycogen Metabolism
Uruno, A., Yagishita, Y., Katsuoka, F., Kitajima, Y., Nunomiya, A., Nagatomi, R., Pi, J., Biswal, S. S., & Yamamoto, M. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.01095-15 · Cited by 126 · see citing works
Self-citationJiang, Z., Lu, M., & You, Q. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00586 · Cited by 126 · see citing works
SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC
Gao, Q., Zhang, G., Zheng, Y., Yang, Y., Chang, C., Xia, J. L., Liang, L., Lei, C., Hu, Y., Cai, X.-F., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0399-1 · Cited by 126 · see citing works
Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects
Galicia‐Moreno, M., Lucano‐Landeros, S., Monroy-Ramírez, H. C., Silva-Gómez, J. A., Gutiérrez‐Cuevas, J., Santos, A., & Armendáriz‐Borunda, J. (2020) · Antioxidants · doi:10.3390/antiox9100980 · Cited by 121 · see citing works
Silva, D. V. T. D., Baião, D. D. S., Ferreira, V. F., & Paschoalin, V. M. F. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1822277 · Cited by 118 · see citing works
Staurengo‐Ferrari, L., Badaro‐Garcia, S., Hohmann, M. S., Manchope, M. F., Zaninelli, T. H., Casagrande, R., & Verri, W. A., Jr. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01536 · Cited by 121 · see citing works
Keap1 as the redox sensor of the antioxidant response
Sihvola, V., & Levonen, A. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.10.010 · Cited by 117 · see citing works
Therapeutic Approaches to Alzheimer’s Disease Through Modulation of NRF2
Bahn, G., & Jo, D. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-018-08523-5 · Cited by 117 · see citing works
Macías‐Rodríguez, R. U., Inzaugarat, M. E., Ruiz‐Margáin, A., Nelson, L. J., Trautwein, C., & Cubero, F. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051651 · Cited by 114 · see citing works
The KEAP1-NRF2 System and Neurodegenerative Diseases
Uruno, A., & Yamamoto, M. P. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0234 · Cited by 111 · see citing works
Self-citationObesity and NRF2-mediated cytoprotection: Where is the missing link?
Mihaylova, L. V., Savova, M. S., Amirova, K. M., Dinkova‐Kostova, A. T., & Georgiev, M. I. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104760 · Cited by 108 · see citing works
Satoh, T., & Lipton, S. A. (2017) · F1000Research · doi:10.12688/f1000research.12111.1 · Cited by 105 · see citing works
Naidu, S. D., Muramatsu, A., Saito, R., Asami, S., Honda, T., Hosoya, T., Itoh, K., Yamamoto, M. P., Suzuki, T., & Dinkova‐Kostova, A. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-26269-9 · Cited by 99 · see citing works
Self-citationPalliyaguru, D. L., Chartoumpekis, D., Wakabayashi, N., Skoko, J., Yagishita, Y., Singh, S. V., & Kensler, T. (2016) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2016.10.003 · Cited by 96 · see citing works
Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy
Sun, H., Wu, Z., Cao, L., Zhu, M., Liu, T.-T., Guo, L., Lin, Y., Nie, X.-W., & Bian, J. (2019) · Molecules · doi:10.3390/molecules24152857 · Cited by 100 · see citing works
Relevance of Nrf2 and heme oxygenase-1 in articular diseases
Alcaraz, M. J., & Ferrándiz, M. L. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.007 · Cited by 98 · see citing works
Chhunchha, B., Kubo, E., & Singh, D. P. (2020) · Cells · doi:10.3390/cells9081861 · Cited by 96 · see citing works
Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis
Hayes, J. D., Naidu, S. D., & Dinkova‐Kostova, A. T. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.12.010 · Cited by 94 · see citing works
Ooi, B. K., Chan, K., Goh, B. H., & Yap, W. H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01308 · Cited by 94 · see citing works
NRF2 signalling in cytoprotection and metabolism
Murakami, S., Kusano, Y., Okazaki, K., Akaike, T., & Motohashi, H. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16246 · Cited by 91 · see citing works
An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment
Keleku-Lukwete, N., Suzuki, M., & Yamamoto, M. P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7358 · Cited by 89 · see citing works
Self-citationRedox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis
Aranda‐Rivera, A. K., Cruz‐Gregorio, A., Aparicio‐Trejo, O. E., Ortega-Lozano, A. J., & Pedraza‐Chaverrí, J. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.034 · Cited by 87 · see citing works
Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer
Chen, F., Xiao, M., Hu, S., & Wang, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1381467 · Cited by 88 · see citing works
Shah, S. Z. A., Zhao, D., Hussain, T. A., Sabir, N., Mangi, M. H., & Yang, L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00310 · Cited by 87 · see citing works
Micheli, L., Bertini, L., Bonato, A., Villanova, N., Caruso, C., Caruso, M., Bernini, R., & Tirone, F. (2023) · Nutrients · doi:10.3390/nu15071767 · Cited by 85 · see citing works
Cheng, Y., Cheng, L., Gao, X., Chen, S., Wu, P., Wang, C., & Liu, Z. (2020) · Theranostics · doi:10.7150/thno.48436 · Cited by 82 · see citing works
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Cores, Á., Piquero, M., Villacampa, M., Leon, R. M., & Menéndez, J. C. (2020) · Biomolecules · doi:10.3390/biom10060904 · Cited by 81 · see citing works
Tkaczenko, H., & Kurhaluk, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031098 · Cited by 80 · see citing works
Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus
Suzuki, T., Seki, S., Hiramoto, K., Naganuma, E., Kobayashi, E. H., Yamaoka, A., Baird, L., Takahashi, N., Sato, H., & Yamamoto, M. P. (2017) · Nature Communications · doi:10.1038/ncomms14577 · Cited by 80 · see citing works
Self-citationNRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis
Duarte, T. L., Talbot, N. P., & Drakesmith, H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8148 · Cited by 77 · see citing works
Patel, V., Dial, K., Wu, J., Gauthier, A. G., Wu, W., Lin, M., Espey, M. G., Thomas, D. D., Ashby, C. R., & Mantell, L. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030977 · Cited by 76 · see citing works
The Role of Organosulfur Compounds as Nrf2 Activators and Their Antioxidant Effects
Egbujor, M. C., Petrosino, M., Zuhra, K., & Saso, L. (2022) · Antioxidants · doi:10.3390/antiox11071255 · Cited by 76 · see citing works
Cis-element architecture of Nrf2–sMaf heterodimer binding sites and its relation to diseases
Otsuki, A., & Yamamoto, M. P. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01193-2 · Cited by 74 · see citing works
Self-citationRoles of the KEAP1-NRF2 system in mammalian skin exposed to UV radiation
Ikehata, H., & Yamamoto, M. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.09.038 · Cited by 73 · see citing works
Self-citationThe Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
Scagliola, A., Mainini, F., & Cardaci, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7974 · Cited by 73 · see citing works
Hyttinen, J. M. T., Kannan, R., Felszeghy, S., Niittykoski, M., Salminen, A., & Kaarniranta, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225800 · Cited by 69 · see citing works
Chakkittukandiyil, A., Sajini, D. V., Karuppaiah, A., & Selvaraj, D. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105325 · Cited by 73 · see citing works
Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Aranda‐Rivera, A. K., Cruz‐Gregorio, A., Pedraza‐Chaverrí, J., & Scholze, A. (2022) · Antioxidants · doi:10.3390/antiox11061112 · Cited by 70 · see citing works
Huerta, C., Jiang, X. J., Isaac, T., Bender, C. F., Ferguson, D. A., Probst, B., Swinger, K. K., Stoll, V. S., Thomas, P., Dulubova, I., et al. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.07.026 · Cited by 69 · see citing works
Regulation of Keap1-Nrf2 signaling in health and diseases
Xiao, J.-L., Liu, H.-Y., Sun, C., & Tang, C. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09771-4 · Cited by 68 · see citing works
Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy
Cui, W., Min, X., Xu, X., Du, B., & Luo, P. (2017) · Journal of Diabetes Research · doi:10.1155/2017/3797802 · Cited by 67 · see citing works
Eisenstein, A. S., Hilliard, B. K., Pope, S. D., Zhang, C., Taskar, P., Waizman, D. A., Israni-Winger, K., Tian, H., Luan, H. H., & Wang, A. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.015 · Cited by 67 · see citing works
Targeting Nrf2 in ischemia-reperfusion alleviation: From signaling networks to therapeutic targeting
Sadrkhanloo, M., Entezari, M., Orouei, S., Zabolian, A., Mirzaie, A., Maghsoudloo, A., Raesi, R., Asadi, N., Hashemi, M., Zarrabi, A., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120561 · Cited by 65 · see citing works
Carbon monoxide – beyond toxicity?
Stucki, D., & Stahl, W. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.08.010 · Cited by 66 · see citing works
An overview of the mechanisms and novel roles of Nrf2 in cardiovascular diseases
Jiang, S., Yang, Y., Li, T. X., Ma, Z., Hu, W., Deng, C., Fan, C., Lv, J., Sun, Y., & Yi, W. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1250887 · Cited by 66 · see citing works
Egbujor, M. C., Buttari, B., Profumo, E., Telkoparan‐Akillilar, P., & Saso, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158466 · Cited by 64 · see citing works
Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications
Vargas-Mendoza, N., Morales‐González, Á., Morales-Martínez, M., Soriano-Ursua, M. A., Delgado‐Olivares, L., Sandoval-Gallegos, E. M., Madrigal‐Bujaidar, E., Álvarez‐González, I., Madrigal‐Santillán, E., & Morales‐González, J. A. (2020) · Biomedicines · doi:10.3390/biomedicines8050122 · Cited by 65 · see citing works
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function
Swamynathan, M. M., Kuang, S., Watrud, K. E., Doherty, M. R., Gineste, C., Mathew, G., Gong, G. Q., Cox, H., Cheng, E., Reiss, D. J., et al. (2024) · Science · doi:10.1126/science.adk9167 · Cited by 64 · see citing works
Yang, T., Sun, Y., Mao, L., Zhang, M., Li, Q., Zhang, L., Shi, Y., Leak, R. K., Chen, J., & Zhang, F. (2018) · Redox Biology · doi:10.1016/j.redox.2018.05.001 · Cited by 63 · see citing works
AHR and NRF2 in Skin Homeostasis and Atopic Dermatitis
Edamitsu, T., Taguchi, K., Okuyama, R., & Yamamoto, M. P. (2022) · Antioxidants · doi:10.3390/antiox11020227 · Cited by 62 · see citing works
Self-citationInsights on the mechanisms of action of ozone in the medical therapy against COVID-19
Chirumbolo, S., Valdenassi, L., Simonetti, V., Bertossi, D., Ricevuti, G., Franzini, M., & Pandolfi, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107777 · Cited by 60 · see citing works
Wu, X., Wei, J., Yi, Y., Gong, Q., & Gao, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1057918 · Cited by 61 · see citing works
Structural and mechanistic insights into the Keap1-Nrf2 system as a route to drug discovery
Madden, S. K., & Itzhaki, L. S. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140405 · Cited by 60 · see citing works
Overview of redox regulation by Keap1–Nrf2 system in toxicology and cancer
Suzuki, M., Otsuki, A., Keleku-Lukwete, N., & Yamamoto, M. P. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.10.001 · Cited by 59 · see citing works
Self-citationRosito, M., Testi, C., Parisi, G., Cortese, B., Baiocco, P., & Angelantonio, S. D. (2020) · Antioxidants · doi:10.3390/antiox9080700 · Cited by 58 · see citing works
Funakohi-Tago, M., Sakata, T., Fujiwara, S., Sakakura, A., Sugai, T., Tago, K., & Tamura, H. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.043 · Cited by 57 · see citing works
Structural basis of transcription regulation by CNC family transcription factor, Nrf2
Sengoku, T., Shiina, M., Suzuki, K., Hamada, K., Sato, K., Uchiyama, A., Kobayashi, S., Oguni, A., Itaya, H., Kasahara, K., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1102 · Cited by 56 · see citing works
Self-citationGinsenosides for therapeutically targeting inflammation through modulation of oxidative stress
Paik, S., Song, G., & Jo, E. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110461 · Cited by 58 · see citing works
Wong, M. H. L., Bryan, H. K., Copple, I. M., Jenkins, R. E., Chiu, P. H., Bibby, J., Berry, N. G., Kitteringham, N. R., Goldring, C. E., O’Neill, P. M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01292 · Cited by 56 · see citing works
Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors
Hayashi, M., Kuga, A., Suzuki, M., Panda, H., Kitamura, H., Motohashi, H., & Yamamoto, M. P. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2888 · Cited by 56 · see citing works
Self-citationRoles of CNC Transcription Factors NRF1 and NRF2 in Cancer
Sekine, H., & Motohashi, H. (2021) · Cancers · doi:10.3390/cancers13030541 · Cited by 51 · see citing works
Phenethyl Isothiocyanate, a Dual Activator of Transcription Factors NRF2 and HSF1
Naidu, S. D., Suzuki, T., Yamamoto, M. P., Fahey, J. W., & Dinkova‐Kostova, A. T. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700908 · Cited by 53 · see citing works
Self-citationFunakoshi‐Tago, M., Nonaka, Y., Tago, K., Takeda, M., Ishihara, Y., Sakai, A., Matsutaka, M., Kobata, K., & Tamura, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-59380-x · Cited by 53 · see citing works
Cvetko, F., Caldwell, S. T., Higgins, M., Suzuki, T., Yamamoto, M. P., Prag, H. A., Hartley, R. C., Dinkova‐Kostova, A. T., & Murphy, M. P. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.016551 · Cited by 54 · see citing works
Self-citationAnti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane
Habtemariam, S. (2024) · Biomedicines · doi:10.3390/biomedicines12061169 · Cited by 54 · see citing works
- Authors
- Saito, R., Suzuki, T., Hiramoto, K., Asami, S., Naganuma, E., Suda, H., Iso, T., Yamamoto, H., Morita, M., Baird, L., Furusawa, Y., Negishi, T., Ichinose, M., & Yamamoto, M.
- Affiliations
- Tohoku University (JP)
- Mochida Pharmaceutical (Japan) (JP)
- Corresponding author
- Suzuki, Takafumi
- Yamamoto, Masayuki
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2016-01-01
- Volume
- 36
- Issue
- 2
- Pages
- 271-284
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC4719294
- OpenAlex
- W2202703189
- Cited by
- 294
- References
- 47
- Citations by year
- 2026: 30 · 2025: 30 · 2024: 23 · 2023: 26 · 2022: 36 · 2021: 21 · 2020: 48 · 2019: 24 · 2018: 28 · 2017: 14 · 2016: 14
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- P-DIRECT
- Ministry of Education, Culture, Sports, Science, and Technology (24249015, 26111002, 26460354, 25112502, 2611010)
- Takeda Science Foundation
- AMED-CREST, Japan Agency for Medical Research and Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- Keap1, Nrf2, oxidative stress, electrophilic stress, Nrf2 inducers, peritoneal macrophages, murine embryonic fibroblasts, cytoprotection
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Amino Acid Sequence, Animals, Cell Line, Cysteine, Cytoskeletal Proteins, Humans, Mice, Transgenic, Molecular Sequence Data, Mutation, Transfection, Sequence Alignment, Oxidative Stress, Amino Acid Substitution, Intracellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, NF-E2-Related Factor 2, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
